Show Notes
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Evren Ozkaya is the Founder & CEO of Supply Chain Wizard and SCW.AI.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Evren, covering:
The job offer that pulled him away from the McKinsey fast track and into the pharma industry Getting hands on experience at Sandoz, delivering real impact before spotting the opportunity to found his own business The moment that triggered the shift from consulting to technology, and the rapid build out of a software platform The decision to spin out the Digital Factory into a standalone company and raise $10m in Series A funding The importance of simplicity and creating a single source of truth on the factory floor Why the industry must move towards interconnected, systems thinking rather than isolated point to point solutions Why strong networks remain a hidden but powerful advantage in the life sciences sector
Evren Ozkaya, Ph.D. is the Founder & CEO of Supply Chain Wizard (a management consulting firm) and SCW.AI (a technology platform company), helping Pharma manufacturers establish and execute cost-effective and scalable digital transformation programs across manufacturing and supply chain domains by leveraging the state-of-the-art technology.
As a former management consultant at McKinsey & Company and a supply chain executive at Sandoz/Novartis, Dr. Ozkaya led various business transformation programs in over 100 companies in industries such as pharmaceuticals, consumer goods, industrial, logistics and private equity.
Evren Ozkaya received his Ph.D. in Industrial and Systems Engineering from Georgia Institute of Technology with his award-winning thesis on Demand Management in Global Supply Chains. Dr. Ozkaya currently serves as the Chair of the Advisory Board at the School of Industrial and Systems Engineering at Georgia Tech, besides his other advisory board roles at Rutgers Business School and Seton Hall University.
Molecule to Market is also sponsored by Bora Pharmaceuticals, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
More from Molecule to Market: Inside the outsourcing space
In this special encore episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Thomas Eldered, Executive Chairman of Flerie. Your host, Raman Sehgal, revisits one of Molecule to Market’s most fascinating founder stories, bringing together Thomas’ original two part conversation into one episode charting the journey from a small Swedish contract manufacturer to a global CDMO powerhouse. Raman and Thomas discuss the pharmaceutical and biotechnology supply chain, covering:
Live from CPHI Milan, Molecule to Market and ramarketing bring together 11 senior leaders from across the global pharma outsourcing sector to tackle some of the industry's biggest trade-offs.
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with:
In this special encore episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mark Bamforth OBE, serial entrepreneur, investor and mentor to CEOs. Your host, Raman Sehgal, revisits one of Molecule to Market’s most memorable conversations, bringing together Mark’s original two-part story of building and selling three biotech CDMOs for a combined value of $2.5bn. Raman and Mark discuss the pharmaceutical and biotechnology supply chain, covering:
In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector through the perspective of pharma-side buyers and external manufacturing leaders. Your host, Raman Sehgal, brings together insights from Daniel Hurni, Felipe Furiati, Frank Binder, and the buyer-side panel from CDMO Live Europe: When Outsourcing Goes Wrong, covering: